Factors associated with treatment failure of patients with psychiatric diseases and injecting drug users in the treatment of genotype 2 or 3 hepatitis C chronic infection-Reference-Cited by-同舟云学术

Factors associated with treatment failure of patients with psychiatric diseases and injecting drug users in the treatment of genotype 2 or 3 hepatitis C chronic infection

Published:2009-08 Issue:7 Volume:29 Page:1051-1055
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:

Author:

Alvarez-Uria Gerardo,Day Jeremy N.,Nasir Anisa J.,Russell Susan K.,Vilar Francisco Javier

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1478-3231.2008.01958.x/fullpdf

Reference28 articles.

1. 1. Strader DB , Wright T , Thomas DL , Seeff LB. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004; 39: 1147-71.

2. 2. Batista-Neves SC , Quarantini LC , de Almeida AG , et al. High frequency of unrecognized mental disorders in HCV-infected patients. Gen Hosp Psychiatry 2008; 30: 80-2.

3. 3. Nguyen HA , Miller AI , Dieperink E , et al. Spectrum of disease in U.S. veteran patients with hepatitis C. Am J Gastroenterol 2002; 97: 1813-20.

4. 4. Aceijas C , Rhodes T. Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy 2007; 18: 352-8.

5. 5. Lacey C , Ellen S , Devlin H , Wright E , Mijch A. Hepatitis C in psychiatry inpatients: testing rates, prevalence and risk behaviours. Australas Psychiatry 2007; 15: 315-9.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO‐C): An open‐label, single‐arm, phase 4, multicentre trial;Health Science Reports;2020-03-15

2. Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy;International Journal of Drug Policy;2018-12

3. Treatment of Chronic Hepatitis C in Patients Receiving Opioid Agonist Therapy;Infectious Disease Clinics of North America;2018-06

4. Multimethod assessment of baseline depression and relationship to hepatitis C treatment discontinuation;The International Journal of Psychiatry in Medicine;2018-01-03

5. Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden;International Journal of Drug Policy;2015-11